Prediction of cerebral infarction after bypass surgery in adult moyamoya disease: combing parameters on 4D perfusion CT with clinical related factors
- PMID: 39607649
- PMCID: PMC11604700
- DOI: 10.1007/s00701-024-06373-8
Prediction of cerebral infarction after bypass surgery in adult moyamoya disease: combing parameters on 4D perfusion CT with clinical related factors
Abstract
Objective: This study aimed to identify predictive factors for cerebral infarction after bypass surgery in adult patients with moyamoya disease (MMD) using quantitative parameters in 4D-CT perfusion software.
Methods: A total of 108 patients who underwent combined revascularization, including superficial temporal artery-middle cerebral artery (STA-MCA) anastomosis and encephalo-duro-myo-synangiosis (EDMS), in our hospital between September 2019 and August 2023 were analyzed retrospectively. Preoperative relative cerebral blood flow (rCBF), relative cerebral blood volume (rCBV), relative mean transit time (rMTT), and relative time to maximum residual function (rTmax) perfusion parameters were obtained using 4D-CT perfusion software. These quantitative parameters, combined with related clinical and angiographic factors, were statistically analyzed using univariate and multivariate regression analyses to determine the significant predictors of cerebral infarction after bypass surgery.
Results: Acute cerebral infarction occurred in 12 patients postoperatively. Univariate analysis showed that a history of previous ischemic events (P = 0.024), higher Suzuki stage (P = 0.006), higher modified Rankin score (mRS) (P = 0.013), rCBV (P = 0.026), rMTT (P = 0.001), and rTmax (P < 0.001) were associated with postoperative cerebral infarction. Further multivariate regression analysis showed that a history of previous ischemic events (OR = 12.830, 95%CI = 1.854-875.672, P = 0.031) and higher rTmax (OR = 16.968, 95%CI = 2.035-141.451, P = 0.009) were independently associated with new postoperative cerebral infarction. The cutoff value for rTmax was 2.025 (AUC = 0.935).
Conclusions: Previous ischemic event history and rTmax greater than 2.025 are independent risk factors for predicting cerebral infarction after combined revascularization with high sensitivity in adult patients with MMD. These patients should be more cautious when deciding on combined revascularization.
Keywords: Adult moyamoya disease; Cerebral infarction; Combined revascularization; RTmax.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics: This study has been approved by our hospital. Informed consent: Informed consent was obtained from all individual participants included in the study. The consent to publish: Our research has been approved by the Medical Ethics Committee of the first affiliated Hospital of Kunming Medical University, and all the patients with moyamoya disease signed the informed consent form. The consetnt to publicly publish identifiable data and figures was obtained from the patients of the study. AI tools: AI assistance is not used in this article. Conflict of interest: The authors declare no competing interests.
Figures





References
-
- Bahr Hosseini M, Liebeskind DS (2018) The role of neuroimaging in elucidating the pathophysiology of cerebral ischemia. Neuropharmacology 134(Pt B):249–258. 10.1016/j.neuropharm.2017.09.032 - PubMed
-
- Bao X-Y, Duan L, Li D-S et al (2012) Clinical features, surgical treatment and long-term outcome in adult patients with moyamoya disease in China. Cerebrovasc Dis 34(4):305–313. 10.1159/000343225 - PubMed
-
- Fujimura M, Bang OY, Kim JS, (2016) Moyamoya disease. Front Neurol Neurosci. 40:204–220. 10.1159/000448314 - PubMed
Publication types
MeSH terms
Grants and funding
- ZX2019-03-05/Yunnan Clinical Medical Center for Neurological and Cardiovascular Diseases
- ZX2019-03-05/Yunnan Clinical Medical Center for Neurological and Cardiovascular Diseases
- ZX2019-03-05/Yunnan Clinical Medical Center for Neurological and Cardiovascular Diseases
- ZX2019-03-05/Yunnan Clinical Medical Center for Neurological and Cardiovascular Diseases
- 82360246/National Natural Science Foundation of China
LinkOut - more resources
Full Text Sources